Drug intelligence / Profile preview

mushroom-derived hemostatic powder

Development stage
Unknown
Lead developer
Xinqiao Hospital
Administration
Topical
01

Overview

Mushroom-derived hemostatic powder (MHP) is a natural, polysaccharide-based hemostatic agent developed by the Department of Gastroenterology at the Second Affiliated Hospital of Army Medical University (Xinqiao Hospital). Primarily derived from the mushroom *Pleurotus ostreatus*, this powder is designed for endoscopic application to control or prevent gastrointestinal bleeding, particularly following procedures such as gastric polypectomy. Its mechanism of action is primarily physical: upon contact with blood, the powder rapidly absorbs water, which concentrates platelets and clotting factors to accelerate the natural coagulation cascade. Simultaneously, it forms a tenacious, adhesive gel that creates a mechanical barrier over the wound, protecting it from gastric acid and promoting healing. MHP is currently being evaluated in clinical trials for its safety and efficacy in reducing post-polypectomy bleeding and managing other gastrointestinal hemorrhagic conditions.

Other names
Mushroom-derived polysaccharide hemostatic powder
02

Targets

F (Coagulation factors)

Beyond the preview

Go deeper on mushroom-derived hemostatic powder.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on mushroom-derived hemostatic powder.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call